| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000036640 |
| Receipt No. | R000038700 |
| Scientific Title | Development study of the Pre-Hospital Traumatic Bleeding Severity Score for the On-Scene Prediction of the Need for Massive Transfusion |
| Date of disclosure of the study information | 2019/09/30 |
| Last modified on | 2019/05/02 (Ver. 1) |
| Basic information | ||
| Public title | Development study of the Pre-Hospital Traumatic Bleeding Severity Score for the On-Scene Prediction of the Need for Massive Transfusion
|
|
| Acronym | Development study of the ph-TBSS for the On-Scene Prediction of the Need for MT
|
|
| Scientific Title | Development study of the Pre-Hospital Traumatic Bleeding Severity Score for the On-Scene Prediction of the Need for Massive Transfusion
|
|
| Scientific Title:Acronym | Development study of the ph-TBSS for the On-Scene Prediction of the Need for MT
|
|
| Region |
|
|
| Condition | ||||
| Condition | Trauma | |||
| Classification by specialty |
|
|||
| Classification by malignancy | Others | |||
| Genomic information | NO | |||
| Objectives | |
| Narrative objectives1 | develop and evaluate the ph-TBSS allowing determination in the pre-hospital setting and analyze the accuracy to predict the need for MT |
| Basic objectives2 | Others |
| Basic objectives -Others | Diagnostic Study |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | the Need for the Massive Transfusion |
| Key secondary outcomes | |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | High Energy Trauma treated by Helicopter Emergency Medical Service | |||
| Key exclusion criteria | Patients suffering a cardiac arrest at the scene | |||
| Target sample size | 1000 | |||
| Research contact person | |||||||
| Last name of lead principal investigator |
|
||||||
| Organization | Advanced Medical Emergency Department and Critical Care Center, Japan Red Cross Maebashi Hospital | ||||||
| Division name | Department of Emergency Medicine and Critical Care Medicine | ||||||
| Zip code | 371-0811 | ||||||
| Address | Advanced Medical Emergency Department and Critical Care Center, Japan Red Cross Maebashi Hospital | ||||||
| TEL | 0272653333 | ||||||
| alongthelongestway2003@yahoo.co.jp | |||||||
| Public contact | |||||||
| 1st name of contact person |
|
||||||
| Organization | Advanced Medical Emergency Department and Critical Care Center, Japan Red Cross Maebashi Hospital | ||||||
| Division name | Department of Emergency Medicine and Critical Care Medicine | ||||||
| Zip code | 371-0811 | ||||||
| Address | Advanced Medical Emergency Department and Critical Care Center, Japan Red Cross Maebashi Hospital | ||||||
| TEL | 0272653333 | ||||||
| Homepage URL | |||||||
| alongthelongestway2003@yahoo.co.jp | |||||||
| Sponsor | |
| Institute | Advanced Medical Emergency Department and Critical Care Center, Japan Red Cross Maebashi Hospital |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Advanced Medical Emergency Department and Critical Care Center, Japan Red Cross Maebashi Hospital |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | JAPAN |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | Japan Red Cross Maebashi Hospital |
| Address | Asakura-Machi 389-1 |
| Tel | 0272653333 |
| alongthelongestway2003@yahoo.co.jp | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | non |
| Publication of results | Unpublished |
| Result | |||||||
| URL related to results and publications | non | ||||||
| Number of participants that the trial has enrolled | 1039 | ||||||
| Results | The median age was 58.0 years, 78.9% were male, blunt trauma was the mechanism of injury in 98.1%, the median Revised Trauma Score was 7.84, and 6.6% underwent MT. The AUC of the ph-TBSS for the MT was 0.97 (Youden Index=17, sensitivity 92.6%, specificity 97.1%). The AUC of the ph-TBSS for MT in ROC comparison analysis was significantly higher than other scores used to predict the need for MT (AUC: ph-TBSS=0.97, Lactate=0.91, Shock Index=0.89, ABC Score=0.83) (P<0.0175). |
||||||
| Results date posted |
|
||||||
| Results Delayed | |||||||
| Results Delay Reason | |||||||
| Date of the first journal publication of results | |||||||
| Baseline Characteristics | 1039 patients who suffered high-energy traumatic injuries and treated by Gunma HEMS. |
||||||
| Participant flow | The medical records of 1039 patients who suffered high-energy traumatic injuries were reviewed and 1025 patients were enrolled in the study after exclusion of 14 patients with incomplete data |
||||||
| Adverse events | No |
||||||
| Outcome measures | Massive Transfusion |
||||||
| Plan to share IPD | |||||||
| IPD sharing Plan description | |||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | Retrospective Diagnostic Study |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000038700 |